Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 194

1.

Mathematical modelling for antibiotic resistance control policy: do we know enough?

Knight GM, Davies NG, Colijn C, Coll F, Donker T, Gifford DR, Glover RE, Jit M, Klemm E, Lehtinen S, Lindsay JA, Lipsitch M, Llewelyn MJ, Mateus ALP, Robotham JV, Sharland M, Stekel D, Yakob L, Atkins KE.

BMC Infect Dis. 2019 Nov 29;19(1):1011. doi: 10.1186/s12879-019-4630-y.

2.

The health and cost burden of antibiotic resistant and susceptible Escherichia coli bacteraemia in the English hospital setting: A national retrospective cohort study.

Naylor NR, Pouwels KB, Hope R, Green N, Henderson KL, Knight GM, Atun R, Robotham JV, Deeny SR.

PLoS One. 2019 Sep 10;14(9):e0221944. doi: 10.1371/journal.pone.0221944. eCollection 2019.

3.

Using hospital network-based surveillance for antimicrobial resistance as a more robust alternative to self-reporting.

Donker T, Smieszek T, Henderson KL, Walker TM, Hope R, Johnson AP, Woodford N, Crook DW, Peto TEA, Walker AS, Robotham JV.

PLoS One. 2019 Jul 25;14(7):e0219994. doi: 10.1371/journal.pone.0219994. eCollection 2019.

4.

Optimising trial designs to identify appropriate antibiotic treatment durations.

Pouwels KB, Yin M, Butler CC, Cooper BS, Wordsworth S, Walker AS, Robotham JV.

BMC Med. 2019 Jun 21;17(1):115. doi: 10.1186/s12916-019-1348-z.

5.

Selection and co-selection of antibiotic resistances among Escherichia coli by antibiotic use in primary care: An ecological analysis.

Pouwels KB, Muller-Pebody B, Smieszek T, Hopkins S, Robotham JV.

PLoS One. 2019 Jun 10;14(6):e0218134. doi: 10.1371/journal.pone.0218134. eCollection 2019.

6.

Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT).

Lyttle MD, Bielicki JA, Barratt S, Dunn D, Finn A, Harper L, Jackson P, Powell CVE, Roland D, Stohr W, Sturgeon K, Wan M, Little P, Faust SN, Robotham J, Hay AD, Gibb DM, Sharland M; PERUKI, GAPRUKI and the CAP-IT trial team.

BMJ Open. 2019 May 22;9(5):e029875. doi: 10.1136/bmjopen-2019-029875.

7.

Comment on 'The distribution of antibiotic use and its association with antibiotic resistance'.

Pouwels KB, Butler CC, Robotham JV.

Elife. 2019 May 3;8. pii: e46561. doi: 10.7554/eLife.46561.

8.

Epidemiology and health-economic burden of urinary-catheter-associated infection in English NHS hospitals: a probabilistic modelling study.

Smith DRM, Pouwels KB, Hopkins S, Naylor NR, Smieszek T, Robotham JV.

J Hosp Infect. 2019 Sep;103(1):44-54. doi: 10.1016/j.jhin.2019.04.010. Epub 2019 Apr 30.

9.

The challenge of antimicrobial resistance: What economics can contribute.

Roope LSJ, Smith RD, Pouwels KB, Buchanan J, Abel L, Eibich P, Butler CC, Tan PS, Walker AS, Robotham JV, Wordsworth S.

Science. 2019 Apr 5;364(6435). pii: eaau4679. doi: 10.1126/science.aau4679. Review.

PMID:
30948524
10.

Duration of antibiotic treatment for common infections in English primary care: cross sectional analysis and comparison with guidelines.

Pouwels KB, Hopkins S, Llewelyn MJ, Walker AS, McNulty CA, Robotham JV.

BMJ. 2019 Feb 27;364:l440. doi: 10.1136/bmj.l440.

11.

Antibiotic resistance, stewardship, and consumption.

Pouwels KB, Chatterjee A, Cooper BS, Robotham JV.

Lancet Planet Health. 2019 Feb;3(2):e66. doi: 10.1016/S2542-5196(18)30283-3. No abstract available.

12.

Identifying English Practices that Are High Antibiotic Prescribers Accounting for Comorbidities and Other Legitimate Medical Reasons for Variation.

Hope EC, Crump RE, Hollingsworth TD, Smieszek T, Robotham JV, Pouwels KB.

EClinicalMedicine. 2018 Dec;6:36-41. doi: 10.1016/j.eclinm.2018.12.003.

13.

Quantifying drivers of antibiotic resistance in humans: a systematic review.

Chatterjee A, Modarai M, Naylor NR, Boyd SE, Atun R, Barlow J, Holmes AH, Johnson A, Robotham JV.

Lancet Infect Dis. 2018 Dec;18(12):e368-e378. doi: 10.1016/S1473-3099(18)30296-2. Epub 2018 Aug 29.

PMID:
30172580
14.

Quantifying where human acquisition of antibiotic resistance occurs: a mathematical modelling study.

Knight GM, Costelloe C, Deeny SR, Moore LSP, Hopkins S, Johnson AP, Robotham JV, Holmes AH.

BMC Med. 2018 Aug 23;16(1):137. doi: 10.1186/s12916-018-1121-8.

15.

Revisiting the winter burden of acute gastroenteritis on hospital beds in England: change in data collection supports analytical method for previously missing values.

Sandmann FG, Jit M, Robotham JV, Deeny SR.

J Hosp Infect. 2018 Sep;100(1):115-117. doi: 10.1016/j.jhin.2018.06.008. Epub 2018 Jun 13. No abstract available.

16.

Prevalence of resistance to antibiotics in children's urinary Escherichia coli isolates estimated using national surveillance data.

Pouwels KB, Robotham JV, McNulty CAM, Muller-Pebody B, Hopkins S.

J Antimicrob Chemother. 2018 Aug 1;73(8):2268-2269. doi: 10.1093/jac/dky159. No abstract available.

PMID:
29726990
17.

Estimating the burden of antimicrobial resistance: a systematic literature review.

Naylor NR, Atun R, Zhu N, Kulasabanathan K, Silva S, Chatterjee A, Knight GM, Robotham JV.

Antimicrob Resist Infect Control. 2018 Apr 25;7:58. doi: 10.1186/s13756-018-0336-y. eCollection 2018.

18.

Estimating the Hospital Burden of Norovirus-Associated Gastroenteritis in England and Its Opportunity Costs for Nonadmitted Patients.

Sandmann FG, Shallcross L, Adams N, Allen DJ, Coen PG, Jeanes A, Kozlakidis Z, Larkin L, Wurie F, Robotham JV, Jit M, Deeny SR.

Clin Infect Dis. 2018 Aug 16;67(5):693-700. doi: 10.1093/cid/ciy167.

19.

Antibiotics in primary care in England: which antibiotics are prescribed and for which conditions?

Dolk FCK, Pouwels KB, Smith DRM, Robotham JV, Smieszek T.

J Antimicrob Chemother. 2018 Feb 1;73(suppl_2):ii2-ii10. doi: 10.1093/jac/dkx504.

20.

Defining the appropriateness and inappropriateness of antibiotic prescribing in primary care.

Smith DRM, Dolk FCK, Pouwels KB, Christie M, Robotham JV, Smieszek T.

J Antimicrob Chemother. 2018 Feb 1;73(suppl_2):ii11-ii18. doi: 10.1093/jac/dkx503.

21.

Actual versus 'ideal' antibiotic prescribing for common conditions in English primary care.

Pouwels KB, Dolk FCK, Smith DRM, Robotham JV, Smieszek T.

J Antimicrob Chemother. 2018 Feb 1;73(suppl_2):19-26. doi: 10.1093/jac/dkx502.

22.

Explaining variation in antibiotic prescribing between general practices in the UK.

Pouwels KB, Dolk FCK, Smith DRM, Smieszek T, Robotham JV.

J Antimicrob Chemother. 2018 Feb 1;73(suppl_2):ii27-ii35. doi: 10.1093/jac/dkx501.

23.

Potential for reducing inappropriate antibiotic prescribing in English primary care.

Smieszek T, Pouwels KB, Dolk FCK, Smith DRM, Hopkins S, Sharland M, Hay AD, Moore MV, Robotham JV.

J Antimicrob Chemother. 2018 Feb 1;73(suppl_2):ii36-ii43. doi: 10.1093/jac/dkx500.

24.

Understanding the gender gap in antibiotic prescribing: a cross-sectional analysis of English primary care.

Smith DRM, Dolk FCK, Smieszek T, Robotham JV, Pouwels KB.

BMJ Open. 2018 Feb 22;8(2):e020203. doi: 10.1136/bmjopen-2017-020203.

25.

Association between use of different antibiotics and trimethoprim resistance: going beyond the obvious crude association.

Pouwels KB, Freeman R, Muller-Pebody B, Rooney G, Henderson KL, Robotham JV, Smieszek T.

J Antimicrob Chemother. 2018 Jun 1;73(6):1700-1707. doi: 10.1093/jac/dky031.

PMID:
29394363
26.

Intensive care unit (ICU)-acquired bacteraemia and ICU mortality and discharge: addressing time-varying confounding using appropriate methodology.

Pouwels KB, Vansteelandt S, Batra R, Edgeworth JD, Smieszek T, Robotham JV.

J Hosp Infect. 2018 May;99(1):42-47. doi: 10.1016/j.jhin.2017.11.011. Epub 2017 Nov 23.

PMID:
29175434
27.

Seasonality of urinary tract infections in the United Kingdom in different age groups: longitudinal analysis of The Health Improvement Network (THIN).

Rosello A, Pouwels KB, Domenech DE Cellès M, VAN Kleef E, Hayward AC, Hopkins S, Robotham JV, Smieszek T, Opatowski L, Deeny SR.

Epidemiol Infect. 2018 Jan;146(1):37-45. doi: 10.1017/S095026881700259X. Epub 2017 Nov 23.

PMID:
29168442
28.

Use of mathematical modelling to assess the impact of vaccines on antibiotic resistance.

Atkins KE, Lafferty EI, Deeny SR, Davies NG, Robotham JV, Jit M.

Lancet Infect Dis. 2018 Jun;18(6):e204-e213. doi: 10.1016/S1473-3099(17)30478-4. Epub 2017 Nov 13. Review.

PMID:
29146178
29.

Estimating the opportunity costs of bed-days.

Sandmann FG, Robotham JV, Deeny SR, Edmunds WJ, Jit M.

Health Econ. 2018 Mar;27(3):592-605. doi: 10.1002/hec.3613. Epub 2017 Nov 6.

30.

Addressing the Unknowns of Antimicrobial Resistance: Quantifying and Mapping the Drivers of Burden.

Knight GM, Costelloe C, Murray KA, Robotham JV, Atun R, Holmes AH.

Clin Infect Dis. 2018 Feb 1;66(4):612-616. doi: 10.1093/cid/cix765.

31.

Gambling with antibiotics: a novel approach for exploring antibiotic consumption decision-making.

Naylor NR, Uchegbu I, Chatterjee A, Robotham JV.

Public Health. 2017 Oct;151:146-148. doi: 10.1016/j.puhe.2017.07.012. Epub 2017 Aug 9. No abstract available.

32.

Identification of a common Ara h 3 epitope recognized by both the capture and the detection monoclonal antibodies in an ELISA detection kit.

Zhao L, Zhao L, Zhang B, Robotham JM, Roux KH, Tang H.

PLoS One. 2017 Aug 11;12(8):e0182935. doi: 10.1371/journal.pone.0182935. eCollection 2017.

33.

Will co-trimoxazole resistance rates ever go down? Resistance rates remain high despite decades of reduced co-trimoxazole consumption.

Pouwels KB, Batra R, Patel A, Edgeworth JD, Robotham JV, Smieszek T.

J Glob Antimicrob Resist. 2017 Dec;11:71-74. doi: 10.1016/j.jgar.2017.07.013. Epub 2017 Jul 31.

PMID:
28774863
34.

Measuring distance through dense weighted networks: The case of hospital-associated pathogens.

Donker T, Smieszek T, Henderson KL, Johnson AP, Walker AS, Robotham JV.

PLoS Comput Biol. 2017 Aug 3;13(8):e1005622. doi: 10.1371/journal.pcbi.1005622. eCollection 2017 Aug.

35.

Is antimicrobial stewardship cost-effective? A narrative review of the evidence.

Naylor NR, Zhu N, Hulscher M, Holmes A, Ahmad R, Robotham JV.

Clin Microbiol Infect. 2017 Nov;23(11):806-811. doi: 10.1016/j.cmi.2017.06.011. Epub 2017 Jun 20. Review.

36.

Burden, duration and costs of hospital bed closures due to acute gastroenteritis in England per winter, 2010/11-2015/16.

Sandmann FG, Jit M, Robotham JV, Deeny SR.

J Hosp Infect. 2017 Sep;97(1):79-85. doi: 10.1016/j.jhin.2017.05.015. Epub 2017 May 25.

37.

The relative importance of large problems far away versus small problems closer to home: insights into limiting the spread of antimicrobial resistance in England.

Donker T, Henderson KL, Hopkins KL, Dodgson AR, Thomas S, Crook DW, Peto TEA, Johnson AP, Woodford N, Walker AS, Robotham JV.

BMC Med. 2017 Apr 27;15(1):86. doi: 10.1186/s12916-017-0844-2.

38.

Does appropriate empiric antibiotic therapy modify intensive care unit-acquired Enterobacteriaceae bacteraemia mortality and discharge?

Pouwels KB, Van Kleef E, Vansteelandt S, Batra R, Edgeworth JD, Smieszek T, Robotham JV.

J Hosp Infect. 2017 May;96(1):23-28. doi: 10.1016/j.jhin.2017.03.016. Epub 2017 Mar 16.

39.

Erratum to: Methods for evaluating medical tests and biomarkers.

Gopalakrishna G, Langendam M, Scholten R, Bossuyt P, Leeflang M, Noel-Storr A, Thomas J, Marshall I, Wallace B, Whiting P, Davenport C, Leeflang M, GopalaKrishna G, de Salis I, Mallett S, Wolff R, Whiting P, Riley R, Westwood M, Kleinen J, Collins G, Reitsma H, Moons K, Zapf A, Hoyer A, Kramer K, Kuss O, Ensor J, Deeks JJ, Martin EC, Riley RD, Rücker G, Steinhauser S, Schumacher M, Riley R, Ensor J, Snell K, Willis B, Debray T, Moons K, Deeks J, Collins G, di Ruffano LF, Willis B, Davenport C, Mallett S, Taylor-Phillips S, Hyde C, Deeks J, Mallett S, Taylor SA, Batnagar G; STREAMLINE COLON Investigators; STREAMLINE LUNG Investigators; METRIC Investigators, Taylor-Phillips S, Di Ruffano LF, Seedat F, Clarke A, Deeks J, Byron S, Nixon F, Albrow R, Walker T, Deakin C, Hyde C, Zhelev Z, Hunt H, di Ruffano LF, Yang Y, Abel L, Buchanan J, Fanshawe T, Shinkins B, Wynants L, Verbakel J, Van Huffel S, Timmerman D, Van Calster B, Leeflang M, Zwinderman A, Bossuyt P, Oke J, O'Sullivan J, Perera R, Nicholson B, Bromley HL, Roberts TE, Francis A, Petrie D, Mann GB, Malottki K, Smith H, Deeks J, Billingham L, Sitch A, Mallett S, Deeks J, Gerke O, Holm-Vilstrup M, Segtnan EA, Halekoh U, Høilund-Carlsen PF, Francq BG, Deeks J, Sitch A, Dinnes J, Parkes J, Gregory W, Hewison J, Altman D, Rosenberg W, Selby P, Asselineau J, Perez P, Paye A, Bessede E, Proust-Lima C, Naaktgeboren C, de Groot J, Rutjes A, Bossuyt P, Reitsma J, Moons K, Collins G, Ogundimu E, Cook J, Le Manach Y, Altman D, Wynants L, Vergouwe Y, Van Huffel S, Timmerman D, Van Calster B, Pajouheshnia R, Groenwold R, Moons K, Reitsma J, Peelen L, Van Calster B, Nieboer D, Vergouwe Y, De Cock B, Pencina MJ, Steyerberg EW, Cooper J, Taylor-Phillips S, Parsons N, Stinton C, Smith S, Dickens A, Jordan R, Enocson A, Fitzmaurice D, Sitch A, Adab P, Francq BG, Boachie C, Vidmar G, Freeman K, Connock M, Taylor-Phillips S, Court R, Clarke A, de Groot J, Naaktgeboren C, Reitsma H, Moons C, Harris J, Mumford A, Plummer Z, Lee K, Reeves B, Rogers C, Verheyden V, Angelini GD, Murphy GJ, Huddy J, Ni M, Good K, Cooke G, Bossuyt P, Hanna G, Ma J, Altman D, Collins G, Moons KGMC, de Groot JAH, Mallett S, Altman DG, Reitsma JB, Collins GS, Moons KGM, Altman DG, Reitsma JB, Collins GS, Kamarudin AN, Kolamunnage-Dona R, Cox T, Ni M, Huddy J, Borsci S, Hanna G, Pérez T, Pardo MC, Candela-Toha A, Muriel A, Zamora J, Sanghera S, Mohiuddin S, Martin R, Donovan J, Coast J, Seo MK, Cairns J, Mitchell E, Smith A, Wright J, Hall P, Messenger M, Calder N, Wickramasekera N, Vinall-Collier K, Lewington A, Pajouheshnia R, Damen J, Groenwold R, Moons K, Peelen L, Messenger M, Cairns D, Smith A, Hutchinson M, Wright J, Hall P, Calder N, Sturgeon C, Mitchel L, Kift R, Christakoudi S, Rungall M, Mobillo P, Montero R, Tsui TL, Kon SP, Tucker B, Sacks S, Farmer C, Strom T, Chowdhury P, Rebollo-Mesa I, Hernandez-Fuentes M, Damen JAAG, Debray TPA, Heus P, Hooft L, Moons KGM, Pajouheshnia R, Reitsma JB, Scholten RJPM, Damen JAAG, Hooft L, Schuit E, Debray TPA, Collins GS, Tzoulaki I, Lassale CM, Siontis GCM, Chiocchia V, Roberts C, Schlüssel MM, Gerry S, Black JA, Heus P, van der Schouw YT, Peelen LM, Moons KGM, Damen JAAG, Debray TPA, Heus P, Hooft L, Moons KGM, Pajouheshnia R, Reitsma JB, Scholten RJPM, Ma J, Altman D, Collins G, Spence G, McCartney D, van den Bruel A, Lasserson D, Hayward G, Vach W, de Jong A, Burggraaff C, Hoekstra O, Zijlstra J, de Vet H, Hunt H, Hyde C, Graziadio S, Allen J, Johnston L, O'Leary R, Power M, Allen J, Graziadio S, Johnson L, O'Leary R, Power M, Waters R, Simpson J, Johnston L, Allen J, Graziadio S, O'Leary R, Waters R, Power M, Mallett S, Fanshawe TR, Phillips P, Plumb A, Helbren E, Halligan S, Taylor SA, Gale A, Mallett S, Sekula P, Altman DG, Sauerbrei W, Mallett S, Fanshawe TR, Forman JR, Dutton SJ, Takwoingi Y, Hensor EM, Nichols TE, Shinkins B, Yang Y, Abel L, Di Ruffano LF, Fanshawe T, Kempf E, Porcher R, de Beyer J, Moons K, Altman D, Reitsma H, Hopewell S, Sauerbrei W, Collins G, Dennis J, Shields B, Jones A, Henley W, Pearson E, Hattersley A; MASTERMIND consortium, Heus P, Damen JAAG, Pajouheshnia R, Scholten RJPM, Reitsma JB, Collins GS, Altman DG, Moons KGM, Hooft L, Shields B, Dennis J, Jones A, Henley W, Pearson E, Hattersley A; MASTERMIND consortium, Scheibler F, Rummer A, Sturtz S, Großelfinger R, Banister K, Ramsay C, Azuara-Blanco A, Cook J, Boachie C, Burr J, Kumarasamy M, Bourne R, Uchegbu I, Borsci S, Murphy J, Hanna G, Uchegbu I, Carter A, Murphy J, Ni M, Marti J, Eatock J, Uchegbu I, Robotham J, Dudareva M, Gilchrist M, Holmes A, Uchegbu I, Borsci S, Monaghan P, Lord S, StJohn A, Sandberg S, Cobbaert C, Lennartz L, Verhagen-Kamerbeek W, Ebert C, Bossuyt P, Horvath A; Test Evaluation Working Group of the European Federation of Clinical Chemistry and Laboratory Medicine, Jenniskens K, Naaktgeboren C, Reitsma J, Moons K, de Groot J, Hyde C, Peters J, Grigore B, Peters J, Hyde C, Hyde C, Ukoumunne O, Peters J, Zhelev Z, Levis B, Benedetti A, Levis AW, Ioannidis JPA, Shrier I, Cuijpers P, Gilbody S, Kloda LA, McMillan D, Patten SB, Steele RJ, Ziegelstein RC, Bombardier CH, Osório FL, Fann JR, Gjerdingen D, Lamers F, Lotrakul M, Loureiro SR, Löwe B, Shaaban J, Stafford L, van Weert HCPM, Whooley MA, Williams LS, Wittkampf KA, Yeung AS, Thombs BD, Peters J, Cooper C, Buchanan J, Nieto T, Smith C, Tucker O, Dretzke J, Beggs A, Rai N, Davenport C, Bayliss S, Stevens S, Snell K, Mallet S, Deeks J, Sundar S, Hall E, Porta N, Estelles DL, de Bono J; CTC-STOP protocol development group.

Diagn Progn Res. 2017 Mar 30;1:11. doi: 10.1186/s41512-017-0011-4. eCollection 2017.

40.

A Risk Assessment of Antibiotic Pan-Drug-Resistance in the UK: Bayesian Analysis of an Expert Elicitation Study.

Carter D, Charlett A, Conti S, Robotham JV, Johnson AP, Livermore DM, Fowler T, Sharland M, Hopkins S, Woodford N, Burgess P, Dobra S.

Antibiotics (Basel). 2017 Mar 7;6(1). pii: E9. doi: 10.3390/antibiotics6010009.

41.

Methods for estimating the burden of antimicrobial resistance: a systematic literature review protocol.

Naylor NR, Silva S, Kulasabanathan K, Atun R, Zhu N, Knight GM, Robotham J.

Syst Rev. 2016 Nov 8;5(1):187.

42.

Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae: an economic evaluation from a hospital perspective.

Otter JA, Burgess P, Davies F, Mookerjee S, Singleton J, Gilchrist M, Parsons D, Brannigan ET, Robotham J, Holmes AH.

Clin Microbiol Infect. 2017 Mar;23(3):188-196. doi: 10.1016/j.cmi.2016.10.005. Epub 2016 Oct 13.

43.

The projected effectiveness of Clostridium difficile vaccination as part of an integrated infection control strategy.

van Kleef E, Deeny SR, Jit M, Cookson B, Goldenberg SD, Edmunds WJ, Robotham JV.

Vaccine. 2016 Nov 4;34(46):5562-5570. doi: 10.1016/j.vaccine.2016.09.046. Epub 2016 Oct 7.

44.

Isolation demand from carbapenemase-producing Enterobacteriaceae screening strategies based on a West London hospital network.

Vella V, Moore LS, Robotham JV, Davies F, Birgand GJ, Otter JA, Brannigan E, Dyakova E, Knight GM, Mookerjee S, Holmes AH.

J Hosp Infect. 2016 Oct;94(2):118-24. doi: 10.1016/j.jhin.2016.04.011. Epub 2016 Apr 22.

45.

Reconstructing transmission trees for communicable diseases using densely sampled genetic data.

Worby CJ, O'Neill PD, Kypraios T, Robotham JV, De Angelis D, Cartwright EJ, Peacock SJ, Cooper BS.

Ann Appl Stat. 2016 Mar;10(1):395-417. Epub 2016 Mar 25.

46.

More Research Is Needed to Quantify Risks, Benefits, and Cost-Effectiveness of Universal Mupirocin Usage.

Deeny SR, Worby CJ, Tosas Auguet O, Cooper BS, Edgeworth J, Cookson B, Robotham JV.

Clin Infect Dis. 2016 May 1;62(9):1193-4. doi: 10.1093/cid/ciw077. Epub 2016 Feb 21. No abstract available.

PMID:
26908798
47.

Cost-effectiveness of national mandatory screening of all admissions to English National Health Service hospitals for meticillin-resistant Staphylococcus aureus: a mathematical modelling study.

Robotham JV, Deeny SR, Fuller C, Hopkins S, Cookson B, Stone S.

Lancet Infect Dis. 2016 Mar;16(3):348-56. doi: 10.1016/S1473-3099(15)00417-X. Epub 2015 Nov 28.

PMID:
26616206
48.

Quantifying the Burden of Hospital-Acquired Bloodstream Infection in Children in England by Estimating Excess Length of Hospital Stay and Mortality Using a Multistate Analysis of Linked, Routinely Collected Data.

Green N, Johnson AP, Henderson KL, Muller-Pebody B, Thelwall S, Robotham JV, Sharland M, Wolkewitz M, Deeny SR.

J Pediatric Infect Dis Soc. 2015 Dec;4(4):305-12. doi: 10.1093/jpids/piu073. Epub 2014 Jul 22.

PMID:
26582869
49.

Impact of mupirocin resistance on the transmission and control of healthcare-associated MRSA.

Deeny SR, Worby CJ, Tosas Auguet O, Cooper BS, Edgeworth J, Cookson B, Robotham JV.

J Antimicrob Chemother. 2015 Dec;70(12):3366-78. doi: 10.1093/jac/dkv249. Epub 2015 Sep 3.

50.

Seasonal changes in the incidence of Escherichia coli bloodstream infection: variation with region and place of onset.

Deeny SR, van Kleef E, Bou-Antoun S, Hope RJ, Robotham JV.

Clin Microbiol Infect. 2015 Oct;21(10):924-9. doi: 10.1016/j.cmi.2015.06.023. Epub 2015 Jun 30.

Supplemental Content

Loading ...
Support Center